Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
The 2022 ADA/EASD consensus recommends a patient-centred approach for the management of T2D that considers cardiovascular disease (CVD) history, weight, hypoglycaemic risk, treatment cost and other patient-related factors
Retatrutide produces greater average weight loss in trials, but cross-trial comparisons should be read with caution
Cutoff values of body fat composition to predict metabolic risk factors with normal waist circumference in Asian Indian population
Transthoracic echocardiography was conducted using a Sonos 5500 system with an 1115 MHz linear transducer
Osorios team tracks how animals fed bioactive-rich diets perform in terms of milk yield and quality